Introducing RapidCert™ Biological Indicator (BI) Sterility TestingNelson Labs’ patent-pending solution for quicker sterility confirmation. Learn More
Header Artwork
Header Artwork

ON-DEMAND WEBINAR

Testing of High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol

Published Date: June 12, 2024

Contamination from ethylene glycol and diethylene glycol in liquid formulation poses a high risk to patient safety. Throughout recent years there have been multiple fatalities reported due to the presence of these contaminants in drug products. This webinar covers the testing of high-risk drug components for ethylene glycol and diethylene glycol.

This webinar is ideal for

  • Pharma manufacturers
  • Compounders
  • CDMOs
  • CROs

Learn more about the presenter below.

20592

Shiri Hecter

M.Sc., ASQ CQA and CSSGB

Shiri Hechter received her master’s degree in organic chemistry from Tel-Aviv University in 2005. During her time at Nelson Labs, Shiri supported the analytical testing of pharmaceutical products.

Complete the form below to access this webinar.